)
Progressive Care (RXMD) investor relations material
Progressive Care Q2 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q2 2024 revenue increased 17% year-over-year to $13.5 million, driven by higher prescription and 340B contract revenue.
Gross profit margin improved to 35% from 31% in the prior year quarter, reflecting better reimbursement rates and higher prescription volumes.
Net loss for Q2 2024 was $9.3 million, mainly due to $9.8 million in impairment losses for goodwill and intangible assets.
The company operates two segments: Pharmacy Operations and Third-Party Administration (TPA).
Positive cash flow from operations was achieved, with a cash balance of $8.5 million as of June 30, 2024.
Financial highlights
Q2 2024 revenues: $13.5M (Q2 2023: $11.6M); 6M 2024 revenues: $28.1M (6M 2023: $22.9M).
Prescription revenue, net of PBM fees, rose 11% to $10.5M; 340B contract revenue grew 41% to $3.0M.
Gross profit for Q2 2024: $4.7M (Q2 2023: $3.6M); gross margin 35% (Q2 2023: 31%).
Operating expenses for Q2 2024: $14.0M (Q2 2023: $2.9M), including $9.8M in impairment losses.
Net loss was $9.3M, compared to $4.6M in Q2 2023.
Outlook and guidance
Management expects current cash position and operating cash flow to support obligations for at least 12 months.
Merger with NextPlat expected to close in early October 2024, pending shareholder approval, with anticipated cost reductions and expanded services.
Revenue growth is expected from expanding pharmacy services, new drugs, and additional 340B contracts.
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)